Aspirin and extended-release dipyridamole vs ACE Inhibitors

Interacting Drugs
Aspirin and extended-release dipyridamole
vs
ACE Inhibitors
Security Level
Minor, Monitor Therapy
Mechanism
ACE Inhibitors: Salicylates may diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF. The effects are likely dose-related. 100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Aspirin and extended-release dipyridamole vs ACE Inhibitors


Other Interactions of Aspirin and extended-release dipyridamole

We are Developing Our database, More results coming soon.

Other Interactions of ACE Inhibitors

We are Developing Our database, More results coming soon.